EUVIMEDScopri EUVIMED
Crossref

Hepatocellular carcinoma 18 F‐FDG PET/CT kinetic parameter estimation based on the advantage actor‐critic algorithm

Jianfeng He, Siming Li, Yiwei Xiong, Yu Yao, Siyu Wang, Sidan Wang, Shaobo Wang

Medical Physics · 2025

DOI: 10.1002/mp.17851 ↗

At a glance

Journal article in Medical Physics, 2025. Written by Jianfeng He and 6 co-authors. Institution: Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Yunnan Key Laboratory of Artificial Intelligence, Ku…. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18. 43 references. Funded by: National Natural Science Foundation of China, Basic Research on the Application of Joint Special Funding of Science and Technology Department of Yunnan Province-Kunming Medical University, Yunnan Provincial Science and Technology Department Social Development Special Project.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Kinetic parameters estimated with dynamic 18 F‐fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography (PET)/computed tomography (CT) help characterize hepatocellular carcinoma (HCC), and deep reinforcement learning (DRL) can improve kinetic parameter estimation.

Purpose

The advantage actor‐critic (A2C) algorithm is a DRL algorithm with neural networks that seek the optimal parameters. The aim of this study was to preliminarily assess the role of the A2C algorithm in estimating the kinetic parameters of 18 F‐FDG PET/CT in patients with HCC. Materials and Methods 18 F‐FDG PET data from 14 liver tissues and 17 HCC tumors obtained via a previously developed, abbreviated acquisition protocol (5‐min dynamic PET/CT imaging supplemented with 1‐min static imaging at 60 min) were prospectively collected. The A2C algorithm was used to estimate kinetic parameters with a reversible double‐input, three‐compartment model, and the results were compared with those of the conventional nonlinear least squares (NLLS) algorithm. Fitting errors were compared via the root‐mean‐square errors (RMSEs) of the time activity curves (TACs).

Results

Significant differences in K 1 , k 2 , k 3 , k 4 , f a , and v b according to the A2C algorithm and k 3 , f a , and v b according to the NLLS algorithm were detected between HCC and normal liver tissues (all p < 0.05). Furthermore, A2C demonstrated superior diagnostic performance over NLLS in terms of k 3 and v b (both p < 0.05 in the Delong test). Notably, A2C yielded a smaller fitting error for normal liver tissue (0.62 ± 0.24 vs. 1.04 ± 1.00) and HCC tissue (1.40 ± 0.42 vs. 1.51 ± 0.97) than did NLLS.

Conclusions

Compared with the conventional postreconstruction NLLS method, the A2C algorithm can more precisely estimate 18 F‐FDG kinetic parameters with a reversible double‐input, three‐compartment model for HCC tumors, attaining better TAC fitting with a lower RMSE.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18AlgorithmsImage Processing, Computer-AssistedHumansKineticsMaleMiddle AgedFemaleAged

Author keywords

PET/CTadvantage actor‐criticdeep reinforcement learninghepatocellular carcinomakinetics

Substances

Fluorodeoxyglucose F18

Authors and institutions

  • Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Yunnan Key Laboratory of Artificial Intelligence, Kunming, Yunnan, China.
  • PET/CT Center, Affiliated Hospital of Kunming University of Science and Technology, First People's Hospital of Yunnan, Kunming, China.

Funding

  • National Natural Science Foundation of China
  • Basic Research on the Application of Joint Special Funding of Science and Technology Department of Yunnan Province-Kunming Medical University
  • Yunnan Provincial Science and Technology Department Social Development Special Project

Cite

APA

He, J., Li, S., Xiong, Y., Yao, Y., Wang, S., Wang, S., & Wang, S. (2025). Hepatocellular carcinoma 18 F‐FDG PET/CT kinetic parameter estimation based on the advantage actor‐critic algorithm. Medical Physics. https://doi.org/10.1002/mp.17851

Vancouver

He J, Li S, Xiong Y, Yao Y, Wang S, Wang S, et al. Hepatocellular carcinoma 18 F‐FDG PET/CT kinetic parameter estimation based on the advantage actor‐critic algorithm. Medical Physics. 2025. doi:10.1002/mp.17851

BibTeX
@article{He2025,
  author = {He, Jianfeng and Li, Siming and Xiong, Yiwei and Yao, Yu and Wang, Siyu and Wang, Sidan and Wang, Shaobo},
  title = {Hepatocellular carcinoma 18 F‐FDG PET/CT kinetic parameter estimation based on the advantage actor‐critic algorithm},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.17851}
}
Start for free →